Efficient estimation in two-stage randomized clinical trials using ranked sets

Area of Science:

• Biostatistics
• Clinical Trial Design
• Survival Analysis

Background:

• Chronic disease clinical trials, such as for cancer, leukemia, and schizophrenia, often involve multi-stage treatment policies.
• Estimating survival probability is crucial but can be complicated by expensive maintenance therapies, leading to budget constraints and the use of simple random sampling in later trial stages.

Purpose of the Study:

• To develop and evaluate a novel clinical trial design using ranked set sampling in the second stage for improved survival probability estimation.
• To address the cost and efficiency challenges associated with expensive maintenance therapies in chronic disease trials.

Main Methods:

• Implemented a two-stage clinical trial design incorporating ranked set sampling for the second stage.
• Conducted simulation studies to compare the performance of the ranked set design against the standard simple random sampling design.
• Developed an unbiased estimator for the overall survival distribution under the proposed design.

Main Results:

• The ranked set sampling design yields an unbiased estimate of the population survival probability.
• Simulation results demonstrate that the ranked set design is more efficient than the conventional design, particularly under budget constraints.
• The proposed method provides a more accurate survival distribution estimate for specific treatment combinations.

Conclusions:

• Ranked set sampling offers a statistically sound and more efficient alternative to simple random sampling in the second stage of clinical trials with expensive treatments.
• This design can lead to more precise survival probability estimations without compromising the integrity of the trial, even with budget limitations.
• The findings have implications for optimizing the design of future clinical trials for chronic diseases requiring costly interventions.